UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2013
Commission File Number:001-33036
Mindray Medical International Limited
Mindray Building, Keji 12th Road South,
Hi-tech Industrial Park, Nanshan,
Shenzhen 518057
People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form20-F or Form40-F.
Form20-F x Form40-F ¨
Indicate by check mark if the registrant is submitting the Form6-K in paper as permitted by RegulationS-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form6-K in paper as permitted by RegulationS-T Rule 101(b)(7): ¨
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
Mindray Medical International Limited (“Mindray”, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 17, 2013.
At the meeting, Mindray shareholders approved there-election of incumbent directors Joyce I-Yin Hsu and Wu Qiyao each to serve a three-year term.
In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Mindray Medical International Limited | ||||
| By: | /s/ Alex Lung | |||
| Name: | Alex Lung | |||
| Title: | Chief Financial Officer | |||
Date: December 19, 2013